Compare AVDL & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVDL | SUPX |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | Ireland | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1996 | 2024 |
| Metric | AVDL | SUPX |
|---|---|---|
| Price | $21.51 | $13.61 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.38 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 295.4K |
| Earning Date | 03-02-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $248,517,000.00 | $3,596,575.00 |
| Revenue This Year | $65.47 | N/A |
| Revenue Next Year | $30.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.88 | 23.88 |
| 52 Week Low | $6.38 | $3.55 |
| 52 Week High | $23.57 | $76.50 |
| Indicator | AVDL | SUPX |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 34.27 |
| Support Level | $21.45 | $13.43 |
| Resistance Level | $21.60 | $14.85 |
| Average True Range (ATR) | 0.08 | 1.10 |
| MACD | -0.05 | 0.78 |
| Stochastic Oscillator | 48.78 | 8.50 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.